Machine learning is driving efforts to classify MS into distinct subtypes that may predict disease course, but two experts debate whether this will advance patient care.
A week-long exhibition at the Houses of Parliament saw MPs encouraged to view the number of their own constituents on the ...
Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal ...
The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging advanced biopharmaceuti ...
Roche's Genentech division has formed an R&D ... using technologies like CRISPR-based gene-editing, and machine learning and artificial intelligence algorithms to design, build, and test cell ...
US-based Eli Lilly's Kisunla drug and Japanese company Eisai's Leqembi (below), two breakthrough drugs for the diagnosis and ...
This is one of the key skills that Vendée Globe sailors must master, and one that generates the most attention and the most ...
3d
Pharmaceutical Technology on MSNAmid deglobalising trade, experts seek AI safeguards for clinical trial supplyThe role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe ...
6d
Irish Examiner on MSNWe tried 2025’s biggest fitness trends from padel to Hyrox – here's what we thoughtFrom reformer pilates to Hyrox, padel, barre and somatic movement - the Irish Examiner's lifestyle team put this year's viral ...
The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.
Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, March 11, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results